These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

269 related items for PubMed ID: 6725216

  • 1. Plasma catecholamine metabolites and early response to haloperidol.
    Bowers MB, Swigar ME, Jatlow PI, Goicoechea N.
    J Clin Psychiatry; 1984 Jun; 45(6):248-51. PubMed ID: 6725216
    [Abstract] [Full Text] [Related]

  • 2. Correlates of early neuroleptic response using a uniform haloperidol dose.
    Bowers MB, Swigar ME, Jatlow PI, Hoffman FJ, Goicoechea N.
    Int Clin Psychopharmacol; 1987 Jul; 2(3):255-60. PubMed ID: 3693868
    [Abstract] [Full Text] [Related]

  • 3. Plasma catecholamine metabolites and treatment response at neuroleptic steady state.
    Bowers MB, Swigar ME, Jatlow PI, Hoffman FJ.
    Biol Psychiatry; 1989 Mar 15; 25(6):734-8. PubMed ID: 2923935
    [Abstract] [Full Text] [Related]

  • 4. Plasma catecholamine metabolites in schizophrenics: evidence for the two-subtype concept.
    Chang WH, Chen TY, Lin SK, Lung FW, Lin WL, Hu WH, Yeh EK.
    Biol Psychiatry; 1990 Mar 01; 27(5):510-8. PubMed ID: 2310806
    [Abstract] [Full Text] [Related]

  • 5. Early neuroleptic response: clinical profiles and plasma catecholamine metabolites.
    Bowers MB, Swigar ME, Jatlow PI, Hoffman FJ, Goicoechea N.
    J Clin Psychopharmacol; 1987 Apr 01; 7(2):83-6. PubMed ID: 2884237
    [Abstract] [Full Text] [Related]

  • 6. Effects of clozapine on plasma catecholamines and relation to treatment response in schizophrenia: a within-subject comparison with haloperidol.
    Brown AS, Gewirtz G, Harkavy-Friedman J, Cooper T, Brébion G, Amador XF, Malaspina D, Gorman JM.
    Neuropsychopharmacology; 1997 Nov 01; 17(5):317-25. PubMed ID: 9348547
    [Abstract] [Full Text] [Related]

  • 7. Sex differences in plasma homovanillic acid in acute psychosis.
    Bowers MB, Swigar ME, Jatlow PI.
    N Engl J Med; 1983 Apr 07; 308(14):845-6. PubMed ID: 6835278
    [No Abstract] [Full Text] [Related]

  • 8. Plasma free homovanillic acid (HVA) as a predictor of clinical response in acute psychosis.
    Mazure CM, Nelson JC, Jatlow PI, Bowers MB.
    Biol Psychiatry; 1991 Sep 01; 30(5):475-82. PubMed ID: 1932395
    [Abstract] [Full Text] [Related]

  • 9. Characteristics of patients with the highest plasma catecholamine metabolite levels.
    Bowers MB, Swigar ME, Hoffman FJ, Goicoechea N.
    Am J Psychiatry; 1988 Feb 01; 145(2):246-8. PubMed ID: 3422545
    [Abstract] [Full Text] [Related]

  • 10. [Erythrocyte ketone reductase activity, total plasma haloperidol and acute psychoses].
    Dutoit D, Thomas P, Leroux JM, Vaiga G, Pommery J, Cottencin O, Erb F, Goudemand M.
    Encephale; 1995 Feb 01; 21(6):417-24. PubMed ID: 8674466
    [Abstract] [Full Text] [Related]

  • 11. Lithium in combination with perphenazine: effect on plasma monoamine metabolites.
    Bowers MB, Mazure CM, Nelson JC, Jatlow PI.
    Biol Psychiatry; 1992 Dec 15; 32(12):1102-7. PubMed ID: 1477190
    [Abstract] [Full Text] [Related]

  • 12. Plasma catecholamine metabolites as markers for psychosis and antipsychotic response in schizophrenia.
    Kelley ME, Yao JK, van Kammen DP.
    Neuropsychopharmacology; 1999 Jun 15; 20(6):603-11. PubMed ID: 10327429
    [Abstract] [Full Text] [Related]

  • 13. [Use of haloperidol in high doses in schizophrenia. Clinical, biochemical and pharmacokinetic study].
    Scatton B, Zarifian E, Bianchetti G, Cuche H, Loo H, Morselli PL.
    Encephale; 1982 Jun 15; 8(1):1-8. PubMed ID: 7094868
    [Abstract] [Full Text] [Related]

  • 14. Early neuroleptic response in psychotic men and women: correlation with plasma HVA and MHPG.
    Bowers MB, Swigar ME, Jatlow PI, Hoffman F, Giocoechea N.
    Compr Psychiatry; 1986 Jun 15; 27(3):181-5. PubMed ID: 2872015
    [No Abstract] [Full Text] [Related]

  • 15. First-episode neuroleptic-free schizophrenics: concentrations of monoamines and their metabolites in plasma and their correlations with clinical responses to haloperidol treatment.
    Nagaoka S, Iwamoto N, Arai H.
    Biol Psychiatry; 1997 Apr 15; 41(8):857-64. PubMed ID: 9099412
    [Abstract] [Full Text] [Related]

  • 16. Plasma concentrations of haloperidol and prolactin and clinical outcome in acutely psychotic patients.
    Aschauer HN, Schönbeck G, Langer G, Koinig G, Resch F, Hatzinger R, Chaudry HR, Sieghart W.
    Pharmacopsychiatry; 1988 Sep 15; 21(5):246-51. PubMed ID: 3227055
    [Abstract] [Full Text] [Related]

  • 17. Plasma prolactin and plasma homovanillic acid: predictors of clinical response in schizophrenia.
    Davila R, Gonzalez MA, Zumarraga M, Andia I, Guimon J, Silva RR, Friedhoff AJ.
    Biol Psychiatry; 1995 Aug 15; 38(4):267-9. PubMed ID: 8547450
    [No Abstract] [Full Text] [Related]

  • 18. Acutely psychotic patients receiving high-dose haloperidol therapy.
    Remington G, Pollock B, Voineskos G, Reed K, Coulter K.
    J Clin Psychopharmacol; 1993 Feb 15; 13(1):41-5. PubMed ID: 8486816
    [Abstract] [Full Text] [Related]

  • 19. Serum prolactin as a correlate of clinical response to haloperidol.
    Van Putten T, Marder SR, Mintz J.
    J Clin Psychopharmacol; 1991 Dec 15; 11(6):357-61. PubMed ID: 1770154
    [Abstract] [Full Text] [Related]

  • 20. Plasma drug and homovanillic acid levels in psychotic patients receiving neuroleptics.
    Harris PQ, Brown SJ, Friedman MJ, Bacopoulos NG.
    Biol Psychiatry; 1984 Jun 15; 19(6):849-60. PubMed ID: 6146355
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.